HK1017855A1 - Antifungal composition with enhanced bioavailability - Google Patents

Antifungal composition with enhanced bioavailability

Info

Publication number
HK1017855A1
HK1017855A1 HK99103016A HK99103016A HK1017855A1 HK 1017855 A1 HK1017855 A1 HK 1017855A1 HK 99103016 A HK99103016 A HK 99103016A HK 99103016 A HK99103016 A HK 99103016A HK 1017855 A1 HK1017855 A1 HK 1017855A1
Authority
HK
Hong Kong
Prior art keywords
antifungal composition
enhanced bioavailability
bioavailability
enhanced
antifungal
Prior art date
Application number
HK99103016A
Other languages
English (en)
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1017855A1 publication Critical patent/HK1017855A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK99103016A 1996-05-24 1999-07-13 Antifungal composition with enhanced bioavailability HK1017855A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65532996A 1996-05-24 1996-05-24
PCT/US1997/019388 WO1998007429A2 (en) 1996-05-24 1997-05-21 Antifungal composition with enhanced bioavailability

Publications (1)

Publication Number Publication Date
HK1017855A1 true HK1017855A1 (en) 1999-12-03

Family

ID=24628452

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103016A HK1017855A1 (en) 1996-05-24 1999-07-13 Antifungal composition with enhanced bioavailability

Country Status (28)

Country Link
EP (1) EP0914127B1 (cs)
JP (1) JP3366648B2 (cs)
KR (1) KR100307427B1 (cs)
CN (1) CN1121860C (cs)
AR (1) AR007250A1 (cs)
AT (1) ATE213632T1 (cs)
AU (1) AU719109B2 (cs)
BR (1) BR9711167A (cs)
CA (1) CA2255663C (cs)
CO (1) CO4840511A1 (cs)
CZ (1) CZ293586B6 (cs)
DE (1) DE69710729T2 (cs)
ES (1) ES2169440T3 (cs)
HK (1) HK1017855A1 (cs)
HU (1) HU221371B1 (cs)
ID (1) ID16956A (cs)
IL (1) IL126979A (cs)
MY (1) MY118988A (cs)
NO (1) NO316997B1 (cs)
NZ (1) NZ332699A (cs)
PE (1) PE68898A1 (cs)
PL (1) PL188401B1 (cs)
RU (1) RU2207119C2 (cs)
SK (1) SK281818B6 (cs)
TR (1) TR199802424T2 (cs)
TW (1) TW504390B (cs)
WO (1) WO1998007429A2 (cs)
ZA (1) ZA974428B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
ATE329579T1 (de) 1999-11-12 2006-07-15 Abbott Lab Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
AR033855A1 (es) * 2001-01-26 2004-01-07 Schering Corp Composiciones y combinaciones de activador(es) del receptor de activacion de proliferacion peroxis0mal (ppar) e inhibidor(es) de absorcion de esterol, el uso de dichas composiciones o combinaciones para la manufactura de un medicamento para el tratamiento para indicaciones vasculares, diabetes, obes
WO2004066981A1 (en) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
EA028054B1 (ru) * 2010-11-01 2017-10-31 Мелинта Терапьютикс, Инк. Фармацевтические композиции
RU2450807C1 (ru) * 2011-05-11 2012-05-20 Общество с ограниченной ответственностью фирма "Вита" Стабилизированный фармацевтический состав с противогрибковым действием
CN103845292A (zh) * 2012-11-29 2014-06-11 正大天晴药业集团股份有限公司 泊沙康唑微丸及其制备方法
US9763934B2 (en) * 2014-03-05 2017-09-19 Professional Compounding Centers Of America Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
ATE204875T1 (de) * 1993-12-21 2001-09-15 Schering Corp Fungizide tetrahydrofurane

Also Published As

Publication number Publication date
AU719109B2 (en) 2000-05-04
NO985447D0 (no) 1998-11-23
RU2207119C2 (ru) 2003-06-27
JP2000509720A (ja) 2000-08-02
TR199802424T2 (xx) 1999-03-22
NZ332699A (en) 2000-01-28
HUP9904265A2 (hu) 2000-04-28
JP3366648B2 (ja) 2003-01-14
NO985447L (no) 1998-11-23
CZ379098A3 (cs) 1999-03-17
DE69710729D1 (de) 2002-04-04
EP0914127A2 (en) 1999-05-12
KR100307427B1 (ko) 2001-12-28
CN1121860C (zh) 2003-09-24
CN1228699A (zh) 1999-09-15
EP0914127B1 (en) 2002-02-27
WO1998007429A3 (en) 1998-04-23
TW504390B (en) 2002-10-01
CZ293586B6 (cs) 2004-06-16
HUP9904265A3 (en) 2000-05-29
ATE213632T1 (de) 2002-03-15
PL188401B1 (pl) 2005-01-31
ZA974428B (en) 1997-11-24
AR007250A1 (es) 1999-10-27
IL126979A (en) 2000-10-31
BR9711167A (pt) 1999-08-17
CA2255663C (en) 2002-08-20
IL126979A0 (en) 1999-09-22
KR20000065222A (ko) 2000-11-06
SK160898A3 (en) 1999-05-07
NO316997B1 (no) 2004-07-19
PE68898A1 (es) 1998-11-10
ES2169440T3 (es) 2002-07-01
CO4840511A1 (es) 1999-09-27
DE69710729T2 (de) 2002-08-14
SK281818B6 (sk) 2001-08-06
AU5939998A (en) 1998-03-06
ID16956A (id) 1997-11-27
WO1998007429A2 (en) 1998-02-26
PL330480A1 (en) 1999-05-24
HU221371B1 (en) 2002-09-28
MY118988A (en) 2005-02-28
CA2255663A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
IL124935A0 (en) Antifungal compositions with improved bioavailability
HK1004222A1 (en) Antifungal sordaridin derivatives
ZA973344B (en) Antifungal compositions.
IL126979A0 (en) Antifungal composition with enhanced bioavailability
HUP9903388A3 (en) Fungicidal composition
IL123715A0 (en) Antifungal compositions
GB9601353D0 (en) Stays
GB9714461D0 (en) Antifungal agent
GB9610624D0 (en) Stays
GB2314376B (en) Stays
GB2331123B (en) Stays
GB2329418B (en) Stays
GB9720096D0 (en) Stays
GB9603722D0 (en) Antifungal
GB9619534D0 (en) Fungicidal composition
ZA974338B (en) Anitfungal compositions with improved bioavailability
GB9611006D0 (en) Antifungal compositions
GB2330622B (en) Stays
GB9604147D0 (en) Antifungal agents
GB9606552D0 (en) Antifungal proteins
GB9604088D0 (en) Antifungal agent
GB9604168D0 (en) Antifungal agent
GB9607235D0 (en) Antifungal agent
GB9722452D0 (en) Stays
HU9600250V0 (en) Multi purpose shoe-last

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140521